Azerbaijan Medical Device Certificate Renewal: The Next-Day Effectiveness Rule

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Paragraph 7.9 provides that the effective date of the certificate issued upon re-registration of a medical device is the day following the date on which the previous certificate ceased to be valid (əvvəlki vəsiqə qüvvədən düşdüyü gündən sonrakı növbəti gün). The same rule applies to medicinal products and pharmacologically active substances (paragraph 6.9).

The purpose of this next-day effectiveness design is clear: to make the old and new certificates join end to end on the timeline and to avoid a gap in import and sales. It is, however, a statutory fiction that does not depend on the actual date of issuance — even if the new certificate is issued before the expiry date, its effective date remains the day after the previous certificate lapsed.

2. Legal basis

  • Resolution of the Cabinet of Ministers of the Republic of Azerbaijan No. 345 of July 18, 2024, on the Rules for the National Registration of Medicinal Products, Pharmacologically Active Substances and Medical Devices, Their Inclusion in the State Register and the Maintenance of the State Register (entered into force on July 19, 2024; Xalq qəzeti, July 20, 2024, No. 151; Collection of Legislation, 2024, No. 7, Article 906; repealed Resolution No. 108 of July 13, 2007, with effect from July 20, 2024): paragraph 7.9 (new device certificate effective from the day following expiry of the previous certificate), paragraph 7.8 (filed at least 7 working days in advance), paragraph 8.1 (valid for 5 years), paragraph 6.9 (for medicinal products the date of the new certificate is the day following expiry of the previous certificate), paragraph 7.2 (validity of the new certificate in change registration is limited by the previous certificate).
  • Law of the Republic of Azerbaijan on Medicinal Products (Dərman vasitələri haqqında, Law of the Republic of Azerbaijan No. 208-IIIQ, adopted on December 22, 2006, entered into force on February 28, 2007, Collection of Legislation of the Republic of Azerbaijan, 2007, No. 2, Article 70), as amended by Law No. 979-VIQD of July 14, 2023 (which added Articles 1-1 and 9-1 as new provisions, Collection of Legislation, 2023, No. 8, Article 1127): Article 6.11 (valid for 5 years), Article 6.12 (products placed into circulation during the validity period may continue to be sold and used until their final use-by date), Article 6.8 (medicinal products 90 days in advance).
  • Resolution of the Cabinet of Ministers of the Republic of Azerbaijan No. 345 of July 18, 2024 (same act): paragraph 10.6 (the register records the expiry of the validity period and the expiry date).

3. Expert insights

Insight 1: Next-day effectiveness and the limitation on change registration are two opposite date logics that must be kept apart. Paragraph 7.9, on re-registration, operates backwards in extension: the new certificate is counted from the day after the previous certificate lapsed and receives the full 5 years (paragraph 8.1). Paragraph 7.2, on change registration, operates forwards with truncation: the validity of the new certificate is limited by the validity of the previous one. Re-registration earns a full cycle, change registration does not — this is the legislator’s design against using change registration as a substitute for re-registration.

Insight 2: The issuance date, the effective date of the new certificate and the lapse date of the old certificate are three different dates. Because paragraph 7.8 allows filing 7 working days in advance and paragraph 7.1 gives the Ministry of Health 7 working days to issue, the new certificate will very likely be issued before the old one expires, yet its effective date remains the day after the expiry date. The ledger must list all three dates separately, and the next re-registration window must be planned backwards from the effective date, not the issuance date.

Insight 3: Article 6.12 provides a fallback for any gap. If issuance does cross the expiry date, Article 6.12 allows products that were placed into domestic circulation during the period of validity of the national registration to continue to be sold and used until their final use-by date. This provision protects existing stock, not new imports — the import permit for new consignments still requires a valid certificate.

Insight 4: Paragraph 10.6 leaves a visible trace of every expiry in the register. The register records the fact that the validity period has expired together with the expiry date, and makes a corresponding entry under Article 6.12. If there is a visible interruption between the old and new certificates, distributors and regulators can both find it. What must remain continuous is not only the legal effect but also the appearance of the public record.

Insight 5: The limitation in paragraph 7.2 means that changes never extend the lifecycle. The validity of a new certificate issued in change registration ends on the expiry date of the previous certificate. Accordingly, no amount of change registration can extend the 5-year cycle by a single day; the only way to extend it is re-registration under paragraph 7.8.

4. Practical recommendations

  1. List three dates separately in the ledger: the issuance date of the new certificate, its effective date (the day after the previous certificate lapsed) and the lapse date of the old certificate.
  2. Plan the next re-registration window backwards from the effective date, not the issuance date.
  3. Do not rely on change registration to extend validity; extension is only possible through re-registration (paragraph 7.8).
  4. Prepare the evidence chain for existing stock under Article 6.12 (import permit, customs declaration, warehouse receipts) in case a gap occurs.
  5. Treat a valid certificate as the precondition for importing new consignments; do not rely on the stock protection of Article 6.12.
  6. Check the continuity between old and new certificates in the published register data, and immediately explain any interruption to the AEC.

5. Verification checklist

  • □ The ledger distinguishes the issuance date, the effective date and the lapse date of the old certificate.
  • □ The next re-registration window has been planned backwards from the effective date.
  • □ The internal position that change registration does not extend validity has been documented.
  • □ The evidence chain for existing stock under Article 6.12 has been prepared.
  • □ The import of new consignments has been confirmed to depend on a valid certificate.
  • □ The continuity of old and new certificates in the register has been checked.

Regulatory information verified as of October 30, 2026.

This article was prepared and translated by GRZAN as part of the international medical device registration guide. For professional support with regulatory submissions in Azerbaijan and other jurisdictions, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail